title: Natalizumab: Increased Vigilance is Required in Treating Patients with Multiple Sclerosis.
authors.affiliation: Department of Neurology, The Ohio State University Medical Center, Columbus, OH, USA michael.racke@osumc.edu.
authors.forename: Michael K
authors.initials: MK
authors.lastname: Racke
authors.forename: Olaf
authors.initials: O
authors.lastname: Stüve